Tau phosphorylation is the most extensively studied, as tau phosphorylation levels in brains of neurodegenerative patients, including AD and frontotemporal dementia, are significantly elevated (Khatoon et al., 1992). This evidence concerns the gene MAPT and Alzheimer disease.